August 11, 2017

Boston Scientific Corporation (NYSE:BSX) Climbs 2.21% After-Hours

Boston Scientific Corporation (NYSE:BSX)’s stock on Thursday traded at beginning with a price of $26.49 and when day-trade ended the stock finally plummeted -1.17% to reach at $26.26. Analyst’s mean target price for BSX is $30.85 while analysts mean recommendation is 1.90. Stock value has moved between $19.6 – 28.54 in last one year.

Analyst’s ratings play a very important role in outlining a stock’s performance. Let us check out how analysts have ranked BSX based on current scenarios. Stock has got OUTPERFORM rating from 9 analyst(s) whereas last month 9 analyst(s) have given outperform rating. SELL rating has been given by 0 analyst(s) and 10 analyst(s) given BUY rating to the stock. Company fiscal year is ending in December and analysts’ consensus recommendation is Outperform for BSX and estimated EPS for next quarter is $ 0.31 .

Boston Scientific Corporation (NYSE:BSX) yearly performance is 9.97% and net profit margin is 9.00%. Annual EPS Growth of past 5 years is -2.80%. The current share price indicates that stock is -7.89% away from its one year high and is moving 33.50% ahead of its 52-week low.

On 10 August 2017, Sirius XM Holdings Inc. (NASDAQ:SIRI) stock price started the day at $5.50 and moved between $5.49 – 5.54 to finally close at $5.50. SIRI’s distance from 20 day simple moving average is -1.07% and distance from 50-Day simple moving average is 1.62%. In last 4 months performance of SIRI was 13.87% while its price to sale ratio is 4.93.

Analysts expect Sirius XM Holdings Inc. (NASDAQ:SIRI) to report $ 0.04 EPS and has got OUTPERFORM rating from 4 of Thomson Reuters analysts and 2 analyst(s) given UNDERPERFORM rating. Analyst’s mean target price for SIRI is $5.56 while analysts mean recommendation is 2.40. Firm LT growth rate is estimated as 19.31 %.

Salesforce.com, inc. (NYSE:CRM)’s stock on Thursday traded at beginning with a price of $89.67 and when day-trade ended the stock finally plummeted -2.76% to reach at $87.63. Analyst’s mean target price for CRM is $101.87 while analysts mean recommendation is 1.90. Stock value has moved between $66.39 – 92.24 in last one year.

Stock has got OUTPERFORM rating from 21 analyst(s) whereas last month 22 analyst(s) have given outperform rating. SELL rating has been given by 1 analyst(s) and 20 analyst(s) given BUY rating to the stock. Company fiscal year is ending in January and analysts’ consensus recommendation is Outperform for CRM and estimated EPS for next quarter is $ 0.36 .

Salesforce.com, inc. (NYSE:CRM) yearly performance is 9.21% and net profit margin is 1.50%. Annual EPS Growth of past 5 years is 69.50%. The current share price indicates that stock is -4.88% away from its one year high and is moving 31.91% ahead of its 52-week low.

Leave a Reply

Your email address will not be published. Required fields are marked *